NCT04383483

Brief Summary

In the course of COVID disease, some patients need intensive care treatment. We aim to find an answer to the question of whether the patient's CRP, ferritin, D-dimer, Oxygen Saturation, lymphocyte count, and body mass index can be used as a criterion for admitting patients with COVID to the intensive see unit.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 12, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

June 15, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2022

Completed
Last Updated

March 29, 2021

Status Verified

March 1, 2021

Enrollment Period

1.6 years

First QC Date

May 7, 2020

Last Update Submit

March 26, 2021

Conditions

Coronavirus as the Cause of Diseases Classified Elsewhere

Keywords

SARS-CoV-2, intensive care

Outcome Measures

Primary Outcomes (2)

  • COVICU score

    With this scoring, identifying patients who may need intensive care early and following them closely will have a positive effect on patient prognosis.

    1 week

  • Values

    Minimum and maximum values will be determined at the end of the study. Higher scores mean a worse outcome

    1 week

Study Arms (1)

CoVID patients admitted to ICU

Patients admitted to the intensive care unit with the diagnosis of COVID

Other: COVICU

Interventions

COVICUOTHER

COVICU

CoVID patients admitted to ICU

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients admitted to the intensive care unit with the diagnosis of COVID

You may qualify if:

  • Patients admitted to the intensive care unit with the diagnosis of COVID

You may not qualify if:

  • \<18 years patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bursa Yüksek Ihtisas Training and Research Hospital

Bursa, Yildirim, 16350, Turkey (Türkiye)

RECRUITING

Study Officials

  • Ali Asan, MD

    Bursa Yuksek Ihtisas Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ali Asan, MD

CONTACT

+905332401067draasan@yahoo.com

Erkan Sayan, MD

CONTACT

+905325972556erkansayan@hotmail.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

May 7, 2020

First Posted

May 12, 2020

Study Start

June 15, 2020

Primary Completion

January 31, 2022

Study Completion

February 28, 2022

Last Updated

March 29, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations

TU(1)